Impact Biomedical Inc.
IBOCIK 0001834105 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K filed Mar 11, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0088Δ-0.000486% similar+227/-224 ¶
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Impact Biomedical Inc.
| Name | Roles | Filings |
|---|---|---|
| Dss, Inc. | 10% Owner | 8 |
| Chan Heng Fai Ambrose | Director10% Owner | 3 |
| Heuszel Frank D | OfficerDirector | 3 |
| Alset Ehome International Inc. | 10% Owner | 2 |
| Alset International Ltd | 10% Owner | 2 |
Showing 1-5 of 7
Page 1 of 2Next
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Impact Biomedical Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Dss, Inc. | 20 | 60% | +28.6% | +32.3% | +92.7% | -79.2% |
| 2 | Heuszel Frank D | 4 | 0% | -31.4% | -27.5% | -22.3% | -48.2% |
| 3 | Chan Heng Fai Ambrose | 12 | 42% | -5.5% | -12.8% | +32.2% | -45.3% |
| 4 | Alset Ehome International Inc. | 11 | 45% | -1.9% | -12.8% | +32.2% | -45.3% |
| 5 | Alset International Ltd | 11 | 45% | -1.9% | -12.8% | +32.2% | -45.3% |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|